We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+5.09%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
AUM
$1.86B
AUM Growth
+$115M
Cap. Flow
+$48.6M
Cap. Flow %
2.61%
Top 10 Hldgs %
53.28%
Holding
1,260
New
103
Increased
238
Reduced
231
Closed
77

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$8.78M
2
AMZN icon
Amazon
AMZN
+$5.64M
3
DIS icon
Walt Disney
DIS
+$5.57M
4
PLTR icon
Palantir
PLTR
+$4.68M
5
RING icon
iShares MSCI Global Gold Miners ETF
RING
+$4.35M

Sector Composition

Rank Sector Weight
1 Technology 26.35%
2 Financials 23.03%
3 Consumer Discretionary 16.24%
4 Communication Services 11.99%
5 Healthcare 7.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGRN
1151
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$366 ﹤0.01%
40
CRIS icon
1152
Curis
CRIS
$3.61M
0
RDHL
1153
Redhill Biopharma
RDHL
$4.02M
0
LQDA icon
1154
Liquidia Corp
LQDA
$6.06B
$288 ﹤0.01%
107
CHGA
1155
Change Agents Corp
CHGA
$2.84M
$268 ﹤0.01%
2
SPXU icon
1156
ProShares UltraPro Short S&P 500
SPXU
$387M
$237 ﹤0.01%
1
EMWP
1157
DELISTED
Eros Media World PLC
EMWP
$237 ﹤0.01%
7
-8
-53% -$322
XBIO icon
1158
Xenetic Biosciences
XBIO
$9.33M
$231 ﹤0.01%
11
SCKT icon
1159
Socket Mobile
SCKT
$5.48M
$223 ﹤0.01%
26
NUGT icon
1160
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$1.4B
$218 ﹤0.01%
4
HYMCZ
1161
DELISTED
Hycroft Mining Holding Corporation Warrant
HYMCZ
$117 ﹤0.01%
268
SCPX
1162
DELISTED
Scorpius Holdings, Inc.
SCPX
0
FRO icon
1163
Frontline
FRO
$9.84B
$100 ﹤0.01%
14
GALT icon
1164
Galectin Therapeutics
GALT
$405M
$87 ﹤0.01%
40
GENE
1165
DELISTED
Genetic Technologies Ltd.
GENE
$83 ﹤0.01%
4
BNBX
1166
DELISTED
BNB PLUS CORP
BNBX
0
UVXY icon
1167
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$276M
0
ELOX
1168
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
0
NNVC icon
1169
NanoViricides
NNVC
$31.7M
$38 ﹤0.01%
8
BLRX
1170
BioLineRX
BLRX
$11.4M
0
BNTC icon
1171
Benitec Biopharma
BNTC
$428M
0
GTE icon
1172
Gran Tierra Energy
GTE
$349M
$21 ﹤0.01%
3
LSTA icon
1173
Lisata Therapeutics
LSTA
$15.2M
$19 ﹤0.01%
1
GRCE
1174
Grace Therapeutics
GRCE
$44.6M
$18 ﹤0.01%
1
MBOT icon
1175
Microbot Medical
MBOT
$99.4M
$9 ﹤0.01%
1

Similar funds

RBC Europe's Q1 2021 Portfolio in Review

As of Q1 2021, RBC Europe held 1,260 positions worth $1.86B, up 6.6% from $1.75B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

RBC Europe's Q1 2021 filing shows 103 new, 238 increased, 231 reduced and 77 closed positions. Its largest new stake was iShares MSCI Global Gold Miners ETF: 152,570 shares worth $4.17M. The largest sale was Endava, an estimated $7.1M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RBC Europe's largest Q1 2021 buy was iShares MSCI Global Gold Miners ETF: 152,570 shares worth $4.17M.
  • RBC Europe added most to Visa in Q1 2021, an estimated $8.78M increase.
  • RBC Europe's biggest Q1 2021 reduction was Endava, cutting an estimated $7.1M.
  • RBC Europe fully exited VanEck Junior Gold Miners ETF in Q1 2021, selling an estimated $999K.
  • RBC Europe's ten largest holdings make up 53% of its $1.86B portfolio in Q1 2021.
  • RBC Europe opened 103 new positions and closed 77 in Q1 2021.
  • RBC Europe's portfolio value rose 6.6% quarter-over-quarter to $1.86B.

Based on RBC Europe's 13F filing for Q1 2021, filed 9 Nov 2023.